MedTrace Logo

Validating a Modified COMPASS 31questionnaire for Treatment Outcomes

NCT05302479 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 35

Last updated 2022-07-21

No results posted yet for this study

Summary

Eligible participants will complete the COMPASS 31 (year), modified COMPASS 31(one month) and the NSI (one month) questionnaires at baseline and complete the modified COMPASS 31 and the NSI after usual care of treatment.

The investigators will

1. Compare results for the COMPASS 31(year) to the modified COMPASS 31(month) at baseline.
2. Compare modified COMPASS 31(month) to the NSI at baseline and post intervention.

Conditions

  • Headache, Migraine
  • Persistent Post Traumatic Headache
  • Cervicogenic Headache

Interventions

OTHER

COMPASS 31 questionnaire

A 31 question questionnaire that measures autonomic symptoms.

Sponsors & Collaborators

  • The Defense and Veterans Brain Injury Center

    collaborator FED

  • The University of Queensland

    collaborator OTHER

  • Brooke Army Medical Center

    lead FED

Principal Investigators

  • Matt H Hammerle, DPT · BAMC-BIRS

Eligibility

Min Age
18 Years
Max Age
64 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-04-15
Primary Completion
2023-09-20
Completion
2023-09-20

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05302479 on ClinicalTrials.gov